Could stem cells restore erectile function? new trial tests the idea

NCT ID NCT07544537

Ongoing Disease control Sponsor: National Scientific Medical Center, Kazakhstan Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether stem cells from a patient's own bone marrow or fat can improve erectile dysfunction better than platelet-rich plasma or standard treatments. One hundred men with organic ED who did not respond to pills will receive one of these therapies. The goal is to see if regenerative medicine can offer a new option for this common condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous mesenchymal stem cells (from bone marrow or fat) and platelet-rich plasma
What this could lead to: If successful, this could point toward a regenerative treatment for erectile dysfunction that repairs tissue rather than just managing symptoms.
What could go wrong: This is a mid-stage trial with only 100 participants, so results may not apply to everyone. Stem cell therapies are still experimental and long-term safety is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERECTILE DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ERECTILE DYSFUNCTION

Contacts and locations

Locations

National Scientific Medical Center

Astana, 010000, Kazakhstan

More trials for these conditions

Other studies related to the condition(s) this trial covers.